These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5582478)

  • 1. [Children with progressive muscular dystrophy and mothers with aminoaciduria].
    Kato F; Tamagawa K
    Iryo; 1967 Jul; 21(7):835-41. PubMed ID: 5582478
    [No Abstract]   [Full Text] [Related]  

  • 2. [AMINOACIDURIA IN PROGRESSIVE MUSCULAR DYSTROPHY].
    GANDULLIA E; GAIERO G
    Minerva Pediatr; 1963 Jun; 15():731-4. PubMed ID: 14060514
    [No Abstract]   [Full Text] [Related]  

  • 3. Change of serum creatine phosphokinase activity after exercise in Duchenne type of progressive muscular dystrophy.
    Nakane K
    Nagoya Med J; 1972 Feb; 17(3):203-16. PubMed ID: 5050757
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative measurements in female siblings and mothers of boys with Duchenne dystrophy.
    Fowler WM; Gardner GW; Taylor RG; Scavarda A; Busheikin JB
    Arch Phys Med Rehabil; 1969 Jun; 50(6):301-10. PubMed ID: 5788486
    [No Abstract]   [Full Text] [Related]  

  • 5. The value of determination of serum creatine phosphokinase activity in detection of carriers of progressive muscular dystrophy.
    Hetnarska L
    Pol Med J; 1968; 7(1):224-7. PubMed ID: 5650194
    [No Abstract]   [Full Text] [Related]  

  • 6. [Certain biochemical disorders in progressive muscular dystrophy].
    Badalian LO; Bondarenko ES; Gusev EI; Lukoianov IuE
    Vestn Akad Med Nauk SSSR; 1968; 23(8):73-82. PubMed ID: 5744497
    [No Abstract]   [Full Text] [Related]  

  • 7. [Membrane effects of insulin in x-chromosome recessive hereditary progressive muscular dystrophy (Duchenne form)].
    Blietz R; Kruchten J; Riedl K; Wagner J
    Hoppe Seylers Z Physiol Chem; 1967 Dec; 348(12):1609-15. PubMed ID: 5586908
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipid peroxidation in children with Duchenne's hereditary myopathy].
    Grinio LP; Orlov ON; Prilipko LL; Kagan VE
    Biull Eksp Biol Med; 1984 Oct; 98(10):423-5. PubMed ID: 6498321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tests of serum creatine phosphokinase activity in patients with progressive muscular dystrophy and their relatives for the detection of genetic carriers].
    László A; Salgó L
    Orv Hetil; 1981 Jun; 122(24):1453-6. PubMed ID: 7290660
    [No Abstract]   [Full Text] [Related]  

  • 10. [Correlation of aminoaciduria and the clinical state of patients with progressive muscular dystrophy].
    Górecka A; Teczyńska T
    Neurol Neurochir Pol; 1969; 3(6):699-704. PubMed ID: 5365626
    [No Abstract]   [Full Text] [Related]  

  • 11. The carrier problem in progressive muscular dystrophy.
    Knight JO; Kakulas BA
    Proc Aust Assoc Neurol; 1970; 7():85-8. PubMed ID: 5514828
    [No Abstract]   [Full Text] [Related]  

  • 12. [Progressive muscle dystrophy. 8. Occurrence, clinical aspects and genetics of types I and II].
    Moser H; Wiesmann U; Richterich R; Rossi E
    Schweiz Med Wochenschr; 1966 Feb; 96(6):169-74 contd. PubMed ID: 4861055
    [No Abstract]   [Full Text] [Related]  

  • 13. A report on two African children with pseudohypertrophic muscular dystrophy.
    Wasunna AE
    East Afr Med J; 1969 Jul; 46(7):437-42. PubMed ID: 5354900
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significances of the elevated activity of serum creatine phosphokinase and transaminase in progressive muscular dystrophy].
    Kondo F; Ikeda M; Abe E; Mue S
    Iryo; 1966 Jul; 20(7):683-93. PubMed ID: 5981769
    [No Abstract]   [Full Text] [Related]  

  • 15. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum enzyme activities in the families of patients with progressive muscular dystrophy].
    Tani J; Yano I; Masaki H; Fukuyama K; Saeki B
    Iryo; 1967 Jul; 21(7):848-53. PubMed ID: 5582480
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current theories on the pathogenesis of muscular dystrophy].
    Davidenkova EF; Shvarts EI; Rozenberg OA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(10):1446-52. PubMed ID: 5139404
    [No Abstract]   [Full Text] [Related]  

  • 18. Muscular dystrophy: clinical, electrical, histological and biochemical study.
    Desai AD; Braganca BM; Divekar AY; Bubelis I; Deshpande DH; Rebello MD
    Neurol India; 1966; 14(4):167-73. PubMed ID: 5977713
    [No Abstract]   [Full Text] [Related]  

  • 19. Body-potassium concentation and rubidium metabolism determined by whole-body counting in Duchenne muscular dystrophy and its genetic carrier state.
    Nagai T; Sugita H; Iinuma TA; Furukawa T; Yashiro S
    J Nucl Med; 1969 Jan; 10(1):1-7. PubMed ID: 5797554
    [No Abstract]   [Full Text] [Related]  

  • 20. Slowly progressive X-linked recessive muscular dystrophy (type 3b). Report of cases and review of the literature.
    Zellweger H; Hanson JW
    Arch Intern Med; 1967 Nov; 120(5):525-35. PubMed ID: 6054585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.